Patient's Query
Hello doctor,
I was told I have dry AMD, and lately, my central vision has been getting blurrier, even with my glasses. I am reading about newer treatments that use stem cells or gene therapy to slow the damage or even help the retina recover.
Please suggest.
Hello,
Welcome to icliniq.com.
I read your query and can understand your concern.
Thank you for your thoughtful and important questions. Dry age-related macular degeneration (AMD) can be a slow but frustrating condition, especially when it starts to affect central vision. I will break down where things currently stand with treatments, including promising newer options and what you should consider when evaluating experimental therapies.
The probable cause is progressive degeneration of the retinal pigment epithelium (RPE) and photoreceptor cells with accumulation of drusen beneath the retina. There are age-related oxidative and inflammatory changes in the macula. OCT (Optical Coherence Tomography) can be done to evaluate retinal thinning and drusen volume. Fundus autofluorescence and angiography are done to monitor progression or signs of conversion to wet AMD. Amsler grid testing is done for at-home visual monitoring. Genetic testing (optional) can be done if enrolling in clinical trials. The differential diagnosis is dry AMD, early conversion to wet AMD, central serous retinopathy (if there is a sudden change), and myopic macular degeneration (if highly nearsighted).
The probable diagnosis is progressive non-exudative (dry) age-related macular degeneration, likely intermediate-stage. The current evidence-based treatment options are AREDS2 (age-related eye disease studies) supplements (vitamins C, E, lutein, zeaxanthin, zinc and copper), which can cause slow progression. Lifestyle changes like quitting smoking, following an antioxidant-rich diet, and controlling blood pressure and cholesterol can be followed.
The emerging and experimental therapies to be followed are Pegcetacoplan (Syfovre). This was recently approved for geographic atrophy seen in advanced dry AMD. It can slow down retinal damage by inhibiting complement factor C3. Gene therapy is still experimental, and it is aimed at delivering protective genes to retinal cells. These are not FDA (Food and Drug Administration) approved for dry AMD.
Stem cell therapy is still in early-phase trials. These involve transplanting RPE cells derived from stem cells to preserve or restore retinal function. Some patients show early promise, but vision recovery is limited and not guaranteed. The preventive measures that can be followed are consistent use of AREDS2 supplements, regular eye exams once every six to twelve months, Amsler grid testing at home to catch early vision changes, using UV (ultraviolet) protective sunglasses when going outdoors, and having blood sugar and blood pressure control (as vascular health supports eye health).
I hope this answers your query.
Let me know if I need to assist you further.
Same symptoms don't mean you have the same problem. Consult a doctor now!
Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.